Concepedia

Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque Instability

Aase Handberg, Mona Skjelland, Annika E. Michelsen, Ellen Lund Sagen, Kirsten Krohg‐Sørensen, David Russell, Arve Dahl, Thor Ueland, Erik Øie, Pål Aukrust,

Stroke · 2008 · 99 citations · 9 references

DOI

Abstract

We propose that sCD36 may be a marker of plaque instability and symptomatic carotid atherosclerosis, possibly at least partly as a result of CD36 release to the circulation from the foam cells within the atherosclerotic lesion.

References

9

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

Maria Febbraio, Eugene A. Podrez, Jonathan D. Smith et al. · Journal of Clinical Investigation · 2000 · 1K citations · Full text

Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype

Eugene A. Podrez, Tatiana V. Byzova, Maria Febbraio et al. · Nature Medicine · 2007 · 489 citations · Full text

, , +15

Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis

Tuva B. Dahl, Arne Yndestad, Mona Skjelland et al. · Circulation · 2007 · 464 citations

Profiles of Matrix Metalloproteinases, Their Inhibitors, and Laminin in Stroke Patients

Solveig Horstmann, Pamela Kalb, James A. Koziol et al. · Stroke · 2003 · 240 citations

CD36, a Novel Receptor for Oxidized Low-Density Lipoproteins, Is Highly Expressed on Lipid-Laden Macrophages in Human Atherosclerotic Aorta

Atsuyuki Nakata, Yumiko Nakagawa, Makoto Nishida et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 179 citations · Full text